S&P 500
5,916.61
-0.4%
-23.85
DJI
42,312.92
-0.9%
-364.32
NASDAQ
$19,123.59
-0.1%
-$19.12
Bitcoin
108,025.00
+3.2%
+3,325.74
AAPL
$206.10
-0.4%
-$0.76
AMZN
$202.17
-0.9%
-$1.90
GOOG
$172.42
+4.3%
+$7.10
META
$644.17
+1.1%
+$7.07
MSFT
$455.86
-0.5%
-$2.31
NVDA
$134.69
+0.2%
+$0.31
TSLA
$344.84
+0.3%
+$1.02
Anixa Biosciences (NASDAQ: ANIX)
$2.63
(-2.6%)
-$0.07
Price as of May 20, 2025, 3:36 p.m. ET
Anixa Biosciences Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Anixa Biosciences Company Info
Anixa Biosciences, Inc. is a biotechnology company, which engages in developing therapies and vaccines that are focused on critical unmet needs in oncology and infectious disease. It operates through the following segments: CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics, Cancer Diagnostics, and Patent Licensing. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.